Laryngeal Diseases
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Narrower: Laryngostenosis 1
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Curcumin for laryngostenosis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Petosemtamab for laryngeal diseases | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy + Volume Modulated Arc Therapy + NIVOLUMAB + IPILIMUMAB for laryngeal diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VMD-928 100 mg Tablet for laryngeal diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VMD-928 Tablet and Pembrolizumab (200 mg) for laryngeal diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.